Contact Us
Company Overview
|
Pipeline / Clinical Trials
|
Science & Discovery
|
Business Development
|
Investors
Overview
|
Stock Data
|
Governance
|
SEC Filings
|
News & Events
|
Presentations
|
Fundamentals
|
Information Request
Press Release Archive
Press Release Archive
2010
>
2009
> 2008 >
2007
>
2006
>
2005
>
2004
>
2003
>
2002
>
2001
December 22, 2008
RegeneRx Updates Schedule for Release of Clinical Trial Information
December 11, 2008
RegeneRx Secures $3 Million in Private Financing
December 8, 2008
Scientists Report that Tβ4 May Have Important Role in Multiple Myeloma
November 18, 2008
Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: RGN, IXS, DLKM, VCRT, GTLT
November 17, 2008
RegeneRx's Experimental Drug Promotes Healing in Patients With Non-Healing Corneal Ulcers
November 4, 2008
RegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment Conference
October 24, 2008
RegeneRx Sponsors "Walk a Mile in My Shoes" for National Epidermolysis Bullosa Awareness Week
October 22, 2008
RegeneRx President and CEO to Speak at 7th Annual BIO Investor Forum
October 1, 2008
RegeneRx to Develop RGN-457 for Cystic Fibrosis
September 22, 2008
RegeneRx Enrolls First Subject in RGN-352 Phase IB Clinical Trial
September 22, 2008
RegeneRx/Sigma-Tau Complete Patient Enrollment of Second Phase II Clinical Trial with RGN-137
September 16, 2008
Researchers Presenting Tβ4 Ophthalmic Data at Military Vision Conference
September 12, 2008
Researcher Receives 2008 European Society of Cardiology Outstanding Achievement Award for Work with Tβ4
September 9, 2008
Research Publication Shows Tβ4 Protects Human Gingival Cells from Damage
September 8, 2008
RegeneRx Successfully Completes Phase IA Clinical Trial
August 20, 2008
RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial
July 31, 2008
RegeneRx Awarded Additional $136,000 from FDA Office of Orphan Products for Phase II Epidermolysis Bullosa Trial
July 3, 2008
RegeneRx Completes Enrollment and Dosing of Phase IA Safety Trial for Potential Heart Drug
July 2, 2008
RegeneRx Receives Second $100,000 Award from State of Maryland to Develop Novel Treatment for Cardiac Reperfusion Injury
June 24, 2008
RegeneRx Receives First Patent on Tβ4's Ability to Repair Lung Damage Resulting from Infections and Other Disorders
May 19, 2008
Researchers Report Thymosin B4 Protects Human Cornea Epithelial Cells Against Oxidative Damage
May 15, 2008
Researchers Report Thymosin B4 Promotes Spinal Cord Nerve Cell Survival and Neurite Outgrowth
April 29, 2008
Dr. Gabriel Sosne Presents Tβ4 Anti-inflammation Data at ARVO
April 24, 2008
International Research Team Publishes Details of TB4's Cardioprotective Effects in Ischemia-Reperfusion Study
April 22, 2008
RegeneRx Receives Ophthalmic Patent in Hong Kong
April 16, 2008
RegeneRx President and CEO Interviewed on ''The Leaders Spot''
March 31, 2008
RegeneRx Biopharmaceuticals, Inc. Updates Dial-In Number for Year End Conference Call
March 28, 2008
RegeneRx Biopharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Results
March 28, 2008
RegeneRx Receives Non-Compliance Warning Letter from Amex for Minor Listing Application Violation
February 29, 2008
RegeneRx Closes Previously Announced Financing
February 28, 2008
Dr. Gabriel Sosne to Present New TB4 Anti-Inflammation Data at ARVO
February 27, 2008
RegeneRx Secures $5 Million in Private Financing
January 29, 2008
RegeneRx Names Drug Products Under Clinical Development
home
|
Contact Us
|
Resources
|
Site Map
|
Search
